トゥレット症候群治療の世界市場レポート 2025年

トゥレット症候群治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.4％で32億4,000万米ドルに成長します。予測期間の成長は、精密医療の進歩、遠隔医療サービスの拡大、デジタルヘルスソリューションの統合、研究資金の増加、補完代替療法の台頭などに起因すると考えられます。予測期間における世界の主な動向には、遺伝子治療の進歩、ケアへのアクセス拡大、非薬理学的介入、世界の共同イニシアティブ、行動療法の出現などが含まれます。

予測されるヘルスケア支出の増加は、トゥレット症候群治療市場の成長を促進します。ヘルスケア支出には、治療、投薬、入院、予防医療など、ヘルスケアサービスや製品に一定期間にわたって支出されるすべての費用が含まれ、集団内の医療費全体を反映しています。この増加は、高度医療技術、高齢化、慢性疾患の蔓延による費用の高騰によって促進されています。トゥレット症候群治療では、ヘルスケア支出は高度な診断ツール、薬、行動療法の開発に費やされます。また、継続的な研究、患者教育、専門医療へのアクセスもサポートしています。例えば、2024年1月に国立衛生研究所が報告したように、米国のヘルスケア支出は2022年に4.1％増の4兆5,000億米ドルに達し、2021年の3.2％増を上回る成長率を記録しました。その結果、ヘルスケア支出の急増がトゥレット症候群治療市場を前進させています。

トゥレット症候群治療市場の主なプレーヤーは、脳の振動を同調させてチックを抑制することによってトゥレット症候群を管理するように設計されたウェアラブルデバイスなどの先進技術の開発に注力しています。これらのウェアラブルデバイスは手首に電気刺激を与え、チックの頻度や強さを軽減するのに役立ちます。例えば、2022年5月、英国のバイオテクノロジー企業であるニューロセラピューティクス社は、トゥレット症候群に合わせた装着型機器の臨床試験を開始しました。この装置は、手首の正中神経に標的電気刺激を与え、チック抑制に関連する脳の振動に影響を与えることを目的としています。非侵襲的でユーザーフレンドリーな治療法として、日常生活に簡単に取り入れられるように設計されており、ユーザーは自宅で快適に装着することができます。腕時計のような控えめなデザインが、利便性と使いやすさをさらに高めています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界トゥレット症候群治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のトゥレット症候群治療市場：成長率分析
• 世界のトゥレット症候群治療市場の実績：規模と成長, 2019-2024
• 世界のトゥレット症候群治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界トゥレット症候群治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のトゥレット症候群治療市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗アドレナリン薬
• 抗精神病薬
• 非定型抗精神病薬
• 炭酸脱水酵素阻害剤抗けいれん薬
• その他の薬物クラス
• 世界のトゥレット症候群治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のトゥレット症候群治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 子供たち
• 成人用
• 世界のトゥレット症候群治療市場抗アドレナリン薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルファ2アドレナリン作動薬
• ベータ遮断薬
• 世界のトゥレット症候群治療市場抗精神病薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定型抗精神病薬
• 非定型抗精神病薬
• 世界のトゥレット症候群治療市場非定型抗精神病薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• リスペリドン
• アリピプラゾール
• 世界のトゥレット症候群治療市場炭酸脱水酵素阻害薬抗てんかん薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• トピラマート
• ゾニサミド
• 世界のトゥレット症候群治療市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドーパミン枯渇剤
• GABA作動薬

第7章 地域別・国別分析

• 世界のトゥレット症候群治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のトゥレット症候群治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• トゥレット症候群治療市場：競合情勢
• トゥレット症候群治療市場：企業プロファイル
  • F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca PLC
• Novartis International AG
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Viatris Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Biogen Inc.
• Eisai Co. Ltd.
• Jazz Pharmaceuticals plc
• Mitsubishi Tanabe Pharma Corporation
• Kyowa Kirin Co. Ltd.
• Amneal Pharmaceuticals
• Mallinckrodt Pharmaceuticals
• Neurocrine Biosciences
• Sunovion Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• トゥレット症候群治療市場2029：新たな機会を提供する国
• トゥレット症候群治療市場2029：新たな機会を提供するセグメント
• トゥレット症候群治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tourette syndrome treatment involves managing symptoms such as tics and behavioral issues through a variety of approaches, including medication, behavioral therapies, and supportive services. The goal is to decrease symptom frequency and severity while enhancing the overall quality of life for individuals with Tourette syndrome.

The main classes of drugs used in tourette syndrome treatment include antiadrenergic agents, antipsychotic agents, atypical antipsychotic agents, carbonic anhydrase inhibitors, anticonvulsants, and others. Antiadrenergic agents work by blocking or inhibiting the effects of adrenaline and noradrenaline. These medications are available through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies, and are utilized in both pediatric and adult contexts.

The tourette syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides tourette syndrome treatment market statistics, including tourette syndrome treatment industry global market size, regional shares, competitors with a tourette syndrome treatment market share, detailed tourette syndrome treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tourette syndrome treatment industry. This tourette syndrome treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tourette syndrome treatment market size has grown strongly in recent years. It will grow from $2.37 billion in 2024 to $2.53 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to advancements in pharmacotherapy, clinical research and understanding, development of supportive therapies, improvements in diagnosis and awareness, and regulatory approvals and guidelines.

The tourette syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $3.24 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to advancements in precision medicine, expansion of telehealth services, integration of digital health solutions, increased research funding, and the rise of complementary and alternative therapies. Major trends in the forecast period include gene therapy advances, expanded access to care, non-pharmacological interventions, global collaborative initiatives, and the emergence of behavioral therapies.

The anticipated rise in healthcare spending is set to drive growth in the tourette syndrome treatment market. Healthcare spending encompasses all expenses on healthcare services and products, including treatments, medications, hospital stays, and preventive care, over a specific period, reflecting the overall healthcare costs within a population. This increase is fueled by the escalating costs of advanced medical technologies, aging populations, and the prevalence of chronic illnesses. In Tourette syndrome treatment, healthcare spending goes towards developing advanced diagnostic tools, medications, and behavioral therapies. It also supports ongoing research, patient education, and access to specialized care. For example, as reported by the National Institutes of Health in January 2024, healthcare spending in the US grew by 4.1% in 2022 to reach $4.5 trillion, marking a faster growth rate than the 3.2% increase seen in 2021. Consequently, the surge in healthcare spending is propelling the tourette syndrome treatment market forward.

Key players in the Tourette syndrome treatment market are concentrating on the development of advanced technologies, such as wearable devices designed to manage Tourette syndrome by entraining brain oscillations to suppress tics. These wearable devices provide electrical stimulation to the wrist, helping to reduce the frequency and intensity of tics. For example, in May 2022, Neurotherapeutics Ltd., a UK-based biotechnology firm, initiated a clinical trial for a wearable device tailored to Tourette syndrome. The device delivers targeted electrical stimulation to the median nerve at the wrist, aiming to influence brain oscillations associated with tic suppression. As a non-invasive and user-friendly treatment, it is designed to be easily incorporated into daily routines, allowing users to wear it at home comfortably. Its discreet, wristwatch-like design adds to its convenience and ease of use.

In April 2022, Saladax Biomedical Inc., a US-based company specializing in therapeutic drug monitoring (TDM) assays, acquired a patent portfolio related to antipsychotic drug testing from Janssen Pharmaceutica NV. for an undisclosed sum. This acquisition positions Saladax Biomedical to potentially enhance diagnostic tests and treatment approaches for Tourette syndrome by leveraging Janssen Pharmaceutica's antipsychotic drug intellectual property. Janssen Pharmaceutica NV., based in Belgium, is a key player in manufacturing, marketing, and distributing antipsychotic drugs utilized in treating tourette syndrome.

Major companies operating in the tourette syndrome treatment market are F Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Biogen Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Amneal Pharmaceuticals, Mallinckrodt Pharmaceuticals, Neurocrine Biosciences, Sunovion Pharmaceuticals Inc., Supernus Pharmaceuticals, Lundbeck AS, Voyager Therapeutics Inc., NeuroSigma Inc.

North America was the largest region in the tourette syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tourette syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tourette syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tourette syndrome treatment market consists of revenues earned by entities by providing services, such as pharmacotherapy, behavioral therapies, neurostimulation techniques, and supportive services used during the process. The market value includes the value of related goods sold by the service provider or included within the service offering. The Tourette syndrome treatment market also includes sales of antipsychotics, wrist devices, and non-antipsychotic medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tourette Syndrome Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tourette syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tourette syndrome treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tourette syndrome treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Antiadrenergic Agents; Antipsychotic Agents; Atypical Antipsychotic Agents; Carbonic Anhydrase Inhibitor Anticonvulsants; Other Drug Classes
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Children; Adult
• Subsegments:
• 1) By Antiadrenergic Agents: Alpha-2 Adrenergic Agonists; Beta-Blockers
• 2) By Antipsychotic Agents: Typical Antipsychotics; Atypical Antipsychotics
• 3) By Atypical Antipsychotic Agents: Risperidone; Aripiprazole
• 4) By Carbonic Anhydrase Inhibitor Anticonvulsants: Topiramate; Zonisamide
• 5) By Other Drug Classes: Dopamine-Depleting Agents; Gabaergic Drugs
• Companies Mentioned: F Hoffmann-La Roche AG; AbbVie Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tourette Syndrome Treatment Market Characteristics

3. Tourette Syndrome Treatment Market Trends And Strategies

4. Tourette Syndrome Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Tourette Syndrome Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tourette Syndrome Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tourette Syndrome Treatment Market Growth Rate Analysis
• 5.4. Global Tourette Syndrome Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tourette Syndrome Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tourette Syndrome Treatment Total Addressable Market (TAM)

6. Tourette Syndrome Treatment Market Segmentation

• 6.1. Global Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiadrenergic Agents
• Antipsychotic Agents
• Atypical Antipsychotic Agents
• Carbonic Anhydrase Inhibitor Anticonvulsants
• Other Drug Classes
• 6.2. Global Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.3. Global Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adult
• 6.4. Global Tourette Syndrome Treatment Market, Sub-Segmentation Of Antiadrenergic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alpha-2 Adrenergic Agonists
• Beta-Blockers
• 6.5. Global Tourette Syndrome Treatment Market, Sub-Segmentation Of Antipsychotic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Typical Antipsychotics
• Atypical Antipsychotics
• 6.6. Global Tourette Syndrome Treatment Market, Sub-Segmentation Of Atypical Antipsychotic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Risperidone
• Aripiprazole
• 6.7. Global Tourette Syndrome Treatment Market, Sub-Segmentation Of Carbonic Anhydrase Inhibitor Anticonvulsants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topiramate
• Zonisamide
• 6.8. Global Tourette Syndrome Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dopamine-Depleting Agents
• Gabaergic Drugs

7. Tourette Syndrome Treatment Market Regional And Country Analysis

• 7.1. Global Tourette Syndrome Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tourette Syndrome Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tourette Syndrome Treatment Market

• 8.1. Asia-Pacific Tourette Syndrome Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tourette Syndrome Treatment Market

• 9.1. China Tourette Syndrome Treatment Market Overview
• 9.2. China Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tourette Syndrome Treatment Market

• 10.1. India Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tourette Syndrome Treatment Market

• 11.1. Japan Tourette Syndrome Treatment Market Overview
• 11.2. Japan Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tourette Syndrome Treatment Market

• 12.1. Australia Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tourette Syndrome Treatment Market

• 13.1. Indonesia Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tourette Syndrome Treatment Market

• 14.1. South Korea Tourette Syndrome Treatment Market Overview
• 14.2. South Korea Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tourette Syndrome Treatment Market

• 15.1. Western Europe Tourette Syndrome Treatment Market Overview
• 15.2. Western Europe Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tourette Syndrome Treatment Market

• 16.1. UK Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tourette Syndrome Treatment Market

• 17.1. Germany Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tourette Syndrome Treatment Market

• 18.1. France Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tourette Syndrome Treatment Market

• 19.1. Italy Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tourette Syndrome Treatment Market

• 20.1. Spain Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tourette Syndrome Treatment Market

• 21.1. Eastern Europe Tourette Syndrome Treatment Market Overview
• 21.2. Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tourette Syndrome Treatment Market

• 22.1. Russia Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tourette Syndrome Treatment Market

• 23.1. North America Tourette Syndrome Treatment Market Overview
• 23.2. North America Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tourette Syndrome Treatment Market

• 24.1. USA Tourette Syndrome Treatment Market Overview
• 24.2. USA Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tourette Syndrome Treatment Market

• 25.1. Canada Tourette Syndrome Treatment Market Overview
• 25.2. Canada Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tourette Syndrome Treatment Market

• 26.1. South America Tourette Syndrome Treatment Market Overview
• 26.2. South America Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tourette Syndrome Treatment Market

• 27.1. Brazil Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tourette Syndrome Treatment Market

• 28.1. Middle East Tourette Syndrome Treatment Market Overview
• 28.2. Middle East Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tourette Syndrome Treatment Market

• 29.1. Africa Tourette Syndrome Treatment Market Overview
• 29.2. Africa Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tourette Syndrome Treatment Market Competitive Landscape And Company Profiles

• 30.1. Tourette Syndrome Treatment Market Competitive Landscape
• 30.2. Tourette Syndrome Treatment Market Company Profiles
  • 30.2.1. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Tourette Syndrome Treatment Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC
• 31.2. Novartis International AG
• 31.3. Takeda Pharmaceutical Company Limited
• 31.4. Eli Lilly and Company
• 31.5. Viatris Inc.
• 31.6. Otsuka Pharmaceutical Co. Ltd.
• 31.7. Biogen Inc.
• 31.8. Eisai Co. Ltd.
• 31.9. Jazz Pharmaceuticals plc
• 31.10. Mitsubishi Tanabe Pharma Corporation
• 31.11. Kyowa Kirin Co. Ltd.
• 31.12. Amneal Pharmaceuticals
• 31.13. Mallinckrodt Pharmaceuticals
• 31.14. Neurocrine Biosciences
• 31.15. Sunovion Pharmaceuticals Inc.

32. Global Tourette Syndrome Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tourette Syndrome Treatment Market

34. Recent Developments In The Tourette Syndrome Treatment Market

35. Tourette Syndrome Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Tourette Syndrome Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tourette Syndrome Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tourette Syndrome Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer